Atrial Fibrillation Pipeline, Technology and Market Forecasts to 2015

Atrial Fibrillation Pipeline, Technology and Market Forecasts to 2015

Summary

GlobalData’s medical device report: “Atrial Fibrillation Systems Pipeline Technology and Market Forecasts to 2015” is an essential source of information and analysis on the global atrial fibrillation market. The report identifies the key trends shaping and driving the dynamism in the global atrial fibrillation market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. The report also analyses the M&A landscape in the global atrial fibrillation market with special focus on the market participants that have been the most M&A active. Most importantly, the report provides valuable insight on the pipeline products within the global atrial fibrillation sector.

Scope

- Annualized global atrial fibrillation market revenues data from 2001 to 2008, forecast forward for 7 years to 2015.
- Analysis and review of the key events and milestones that will impact the future of the global atrial fibrillation market. Each trend independently researched to provide qualitative analysis of what the implications on sectors are, and how are companies responding to these trends.
- Insightful review of key industry drivers, restraints and challenges which are likely to impact the global atrial fibrillation market in the long run.
- In-depth analysis of the M&A landscape with a strong emphasis on the market players, likely to remain active in the near future.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Comprehensive analysis of the most likely developments expected to bring a shift to the market positions of the leading manufacturers.
- The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData’s team of industry experts.

Reasons to buy

- Develop business strategies by understanding the trends shaping and driving the global atrial fibrillation market.
- Identify key players best positioned to take advantage of the emerging market opportunities by developing insight on the prevalent and anticipated competitive landscape.
- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global atrial fibrillation market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- Support your go/non-go dilemma by identifying the markets that are least competitive and present significant opportunities for innovation and growth.
- Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.

Keywords

Catheter ablation market, electrophysiology, pipeline products, ablation, competitive analysis, company share, market share, pipeline products, drivers, restraints, volume

1 Table Of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Atrial Fibrillation Pipeline Technology and Market Forecasts to 2015 7
2.1 Introductions and Definitions 7
2.1.1 Electrophysiology 7
2.1.1.1 Electrophysiology Ablation Catheter 7
2.1.1.2 Electrophysiology Diagnostic Catheter 7
2.1.1.3 Electrophysiology Lab Systems 7
2.2 Executive Summary 8
3 Atrial Fibrillation Technology Landscape 9
3.1 Atrial Fibrillation: Overview 9
3.2 Atrial Fibrillation Ablation 10
3.3 Atrial Fibrillation Clinical Trials 11
3.3.1 Comparison of ablation to drug therapy for atrial fibrillation 11
3.3.2 Catheter Ablation Versus Anti-arrhythmic Drug Therapy for Atrial Fibrillation 12
3.3.3 Study of Ablation Versus antiaRrhythmic Drugs in Persistent Atrial Fibrillation 12
3.3.4 Ablation or Surgery for Atrial Fibrillation (AF) Treatment 13
3.3.5 Tailored Treatment of Permanent Atrial Fibrillation 13
3.4 Comparative Effectiveness Research for Radiofrequency Catheter Ablation of Atrial Fibrillation 14
4 Global Atrial Fibrillation Ablation Catheters Market 15
4.1 Market Overview 15
4.2 Atrial Fibrillation Ablation Catheters Cross Country Analysis of Revenue 16
4.3 Atrial Fibrillation Ablation Catheters Market Trends 17
4.3.1 Atrial Fibrillation Ablation Catheters Market Drivers 17
4.3.2 Atrial Fibrillation Market Restraints 17
4.4 Atrial Fibrillation Ablation Catheters Emerging Trends 18
5 Global Electrophysiology Market 19
5.1 Market Overview 19
5.2 Electrophysiology Cross Segment Analysis 21
5.3 Electrophysiology Cross Country Analysis 23
5.4 Competitive Landscape 25
6 Atrial Fibrillation Ablation Catheters Pipeline Products 27
6.1 TactiCath 27
6.1.1 Product Status 27
6.1.2 Product Description 27
6.1.3 Clinical Trial 27
6.2 Pulmonary Vein Ablation Catheter 28
6.2.1 Product Status 28
6.2.2 Product Description 28
6.2.3 Clinical Trial One 28
6.2.4 Clinical Trial Two 29
6.2.5 Clinical Trial Three 29
6.3 CoolFlex Ablation Catheter 30
6.3.1 Product Status 30
6.3.2 Product Description 30
6.4 Cryo Balloon Catheter 31
6.4.1 Product Status 31
6.4.2 Product Description 31
6.5 Multi-Array Ablation Catheter 32
6.5.1 Product Status 32
6.5.2 Product Description 32
6.5.3 Clinical Trial 33
7 Global Atrial Fibrillation Ablation Catheters Pipeline Product Summary 34
8 Future Outlook 35
9 Appendix 36
9.1 Research Methodology 36
9.2 Coverage 37
9.3 Secondary Research 38
9.4 Primary Research 38
9.5 Models 39
9.6 Forecasts 39
9.7 Expert Panels 39
9.8 GlobalData Consulting 40
9.9 Contact Us 40
9.10 Disclaimer 40